Revenue decreased 18.8%
Revenue changed -18.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed -18.8% from the comparable as-filed period.
Working capital changed -121.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Inventory / revenue changed -2940 basis points from the comparable as-filed period.
R&D / revenue changed -478 basis points from the comparable as-filed period.
Receivables / revenue changed +5728 basis points from the comparable as-filed period.
Total assets changed -7.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed +0.2% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.